PROCESSA PHARMACEUTICALS ANNOUNCES UP-LISTING TO OTCQB MARKET
December 06, 2018 09:00 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of...
FluoroPharma Medical, Inc..png
FPMI Restructures CardioPET License With Massachusetts General Hospital
September 27, 2018 09:00 ET | FluoroPharma Medical, Inc.
MONTCLAIR, NJ, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that it has reached an agreement with The General Hospital Corporation,...
logo.jpg
HOVERINK BIOTECHNOLOGIES APPOINTS VSTOCK TRANSFER, LLC AS ITS TRANSFER AGENT AND REGISTRAR
July 11, 2018 10:24 ET | Hoverink Biotechnologies, Inc
LOS ANGELES, CA, July 11, 2018 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES Appoints VSTOCK TRANSFER, LLC as its TRANSFER AGENT AND REGISTRAR Hoverink Biotechnologies is currently developing IV and...
logo.png
Marina Biotech Announces a New Publication on Prestalia®
February 27, 2018 10:15 ET | Marina Biotech, Inc.
City of Industry, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
logo.png
Marina Biotech Announces Agreement for Drug Development and Licensing with Autotelic Bio
January 16, 2018 08:40 ET | Marina Biotech, Inc.
City of Industry, CA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...